We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI'... Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests. Show more
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results PR Newswire SALT LAKE CITY, May 9, 2024 SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY, April 25, 2024 SALT LAKE CITY, April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan PR Newswire SALT LAKE CITY, April 24, 2024 SALT LAKE CITY, April 24, 2024 /PRNewswire/ -- Co-Diagnostics...
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event PR Newswire SALT LAKE CITY, April 12, 2024 Ribbon-cutting included support from Mayor Wood of South...
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions PR Newswire SALT LAKE CITY, April 4, 2024 SALT LAKE CITY, April 4, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX...
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address PR Newswire SALT LAKE CITY, March 21, 2024 Presentation included announcement of the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -8.26446280992 | 1.21 | 1.3 | 1.03 | 62765 | 1.17967661 | CS |
4 | -0.07 | -5.93220338983 | 1.18 | 1.3 | 1.03 | 53248 | 1.16989744 | CS |
12 | -0.04 | -3.47826086957 | 1.15 | 1.3 | 1.02 | 59729 | 1.15111097 | CS |
26 | -0.02 | -1.76991150442 | 1.13 | 1.6567 | 1.02 | 84837 | 1.25520019 | CS |
52 | -0.27 | -19.5652173913 | 1.38 | 1.89 | 0.975 | 90554 | 1.26690003 | CS |
156 | -6.29 | -85 | 7.4 | 11.82 | 0.975 | 377667 | 7.01420264 | CS |
260 | 0.02 | 1.83486238532 | 1.09 | 31.4 | 0.694 | 1606245 | 11.11839957 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions